Double maintains 3 strategies that include TXG - 10X Genomics, Inc.
Current Value
$11.021 Year Return
Current Value
$11.021 Year Return
Yahoo
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
Yahoo
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
Yahoo
Biotech company 10x Genomics (NASDAQ:TXG) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 9.8% year on year to $154.9 million. On the other hand, next quarter’s revenue guidance of $140 million was less impressive, coming in 3.6% below analysts’ estimates. Its non-GAAP loss of $0.10 per share was 64.9% above analysts’ consensus estimates.
Yahoo
The average of price targets set by Wall Street analysts indicates a potential upside of 43.1% in 10x Genomics (TXG). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Yahoo
A number of stocks jumped in the morning session after the major indices rebounded (Nasdaq +2.0%, S&P 500 +1.5%) as President Trump postponed the planned 50% tariff on European Union imports, shifting the start date to July 9, 2025. Companies with substantial business ties to Europe likely had some relief as the delay reduced near-term cost pressures and preserved cross-border demand.
Yahoo
Gene sequencing technology company 10x Genomics (NASDAQ: TXG) hasn't been having it easy in the past few days on the stock market. Despite that, Savant maintained his overweight (buy, in other words) recommendation on the shares. Among these was Canaccord Genuity's Kyle Mikson, who made a more cautious reduction to his 10x Genomics fair value assessment.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -45.13% | $291.48M | 1.43% |
VIXY | -42.82% | $185.08M | 0.85% |
TAIL | -41.88% | $101.78M | 0.59% |
IVOL | -34.49% | $349.05M | 1.02% |
STPZ | -21.32% | $445.04M | 0.2% |
XONE | -21.15% | $640.90M | 0.03% |
FTSD | -19.11% | $228.56M | 0.25% |
VTIP | -17.61% | $15.17B | 0.03% |
SCHO | -16.39% | $10.92B | 0.03% |
SPTS | -15.95% | $5.74B | 0.03% |
CTA | -14.75% | $1.09B | 0.76% |
LDUR | -14.41% | $919.37M | 0.5% |
IBTG | -14.19% | $1.96B | 0.07% |
VGSH | -13.60% | $22.55B | 0.03% |
SHYM | -13.50% | $329.29M | 0.35% |
UTWO | -13.26% | $372.79M | 0.15% |
IBTH | -12.40% | $1.58B | 0.07% |
STIP | -11.95% | $12.62B | 0.03% |
TDTT | -11.36% | $2.61B | 0.18% |
ULST | -11.30% | $668.01M | 0.2% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
TECH | 62.96% | $7.86B | -32.75% | 0.64% |
A | 59.63% | $32.82B | -14.37% | 0.83% |
BRKR | 58.90% | $5.82B | -42.46% | 0.51% |
RVTY | 58.39% | $11.13B | -12.00% | 0.29% |
PACB | 57.63% | $393.11M | -20.36% | 0.00% |
BIO | 56.73% | $6.31B | -19.72% | 0.00% |
POWI | 55.38% | $3.04B | -26.50% | 1.53% |
IQV | 55.11% | $26.75B | -27.36% | 0.00% |
BEAM | 53.93% | $1.71B | -26.67% | 0.00% |
AZTA | 53.54% | $1.37B | -46.56% | 0.00% |
NOVT | 53.44% | $4.39B | -26.19% | 0.00% |
SITE | 53.33% | $5.24B | -10.73% | 0.00% |
PK | 53.32% | $2.04B | -29.93% | 9.75% |
MTD | 53.14% | $23.81B | -22.66% | 0.00% |
TMO | 53.07% | $148.19B | -31.03% | 0.42% |
CERS | 53.03% | $256.15M | -20.71% | 0.00% |
DHR | 52.91% | $139.15B | -24.49% | 0.58% |
TRU | 52.80% | $16.55B | +18.96% | 0.52% |
RGEN | 52.79% | $6.60B | -4.44% | 0.00% |
CXT | 52.58% | $3.13B | -13.77% | 1.20% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
SGOV | 0.11% | $49.06B | 0.09% |
IBTF | 0.15% | $2.07B | 0.07% |
CANE | 0.19% | $9.87M | 0.29% |
VNLA | 0.33% | $2.58B | 0.23% |
XBIL | -0.43% | $795.25M | 0.15% |
BILZ | 0.72% | $840.74M | 0.14% |
SMMU | -0.76% | $874.35M | 0.35% |
PULS | 0.83% | $11.55B | 0.15% |
CARY | -0.86% | $347.36M | 0.8% |
FMHI | 0.96% | $752.22M | 0.7% |
SCHP | 1.00% | $12.80B | 0.03% |
GTIP | 1.03% | $161.77M | 0.12% |
KRBN | 1.04% | $164.42M | 0.85% |
STXT | 1.10% | $128.22M | 0.49% |
DFIP | 1.11% | $912.11M | 0.11% |
IBTO | 1.20% | $341.53M | 0.07% |
TDTF | -1.23% | $818.70M | 0.18% |
TYA | -1.29% | $147.80M | 0.15% |
IEF | 1.40% | $34.13B | 0.15% |
LMBS | 1.42% | $5.06B | 0.64% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CBOE | -24.88% | $23.83B | +34.36% | 1.10% |
ED | -16.18% | $36.29B | +11.44% | 3.33% |
DUK | -12.52% | $89.06B | +14.55% | 3.64% |
CME | -11.76% | $98.05B | +38.45% | 3.91% |
T | -10.94% | $199.03B | +53.24% | 4.01% |
MCK | -10.11% | $91.20B | +20.89% | 0.39% |
AWK | -9.31% | $27.52B | +8.15% | 2.21% |
MO | -8.58% | $100.21B | +32.79% | 6.87% |
EXC | -8.36% | $42.77B | +21.44% | 3.67% |
FMTO | -7.63% | $4.80K | -99.92% | 0.00% |
COR | -7.23% | $57.52B | +25.11% | 0.73% |
K | -6.71% | $27.39B | +34.25% | 2.89% |
HUSA | -5.90% | $27.45M | +41.13% | 0.00% |
VSTA | -5.73% | $350.48M | +43.28% | 0.00% |
PULM | -5.64% | $28.76M | +310.16% | 0.00% |
KR | -5.57% | $43.63B | +26.05% | 1.89% |
GO | -5.36% | $1.28B | -37.44% | 0.00% |
DAO | -4.99% | $273.71M | +140.38% | 0.00% |
KMB | -4.70% | $42.46B | -9.68% | 3.87% |
VZ | -4.40% | $175.69B | +3.97% | 6.46% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
KO | 0.02% | $297.90B | +10.51% | 2.88% |
AMT | 0.09% | $100.87B | +11.78% | 3.09% |
HIHO | -0.13% | $7.62M | -16.02% | 4.05% |
NEUE | -0.27% | $61.16M | +29.49% | 0.00% |
BTCT | 0.29% | $19.62M | +36.77% | 0.00% |
TEF | -0.32% | $29.46B | +22.25% | 9.27% |
ENB | -0.32% | $98.07B | +29.25% | 5.90% |
GFI | -0.33% | $21.77B | +73.47% | 2.28% |
TGI | -0.35% | $2.00B | +80.84% | 0.00% |
FATBB | 0.36% | $41.35M | -27.49% | 12.07% |
PRPO | 0.49% | $16.41M | +103.92% | 0.00% |
WTRG | 0.55% | $10.48B | +1.11% | 3.49% |
VHC | -0.64% | $33.48M | +63.90% | 0.00% |
UUU | -0.85% | $7.08M | +91.25% | 0.00% |
ALL | 0.94% | $51.82B | +22.25% | 1.96% |
JNJ | 0.97% | $362.67B | +3.49% | 3.34% |
PM | 1.01% | $284.24B | +80.37% | 2.94% |
WEC | 1.02% | $33.14B | +33.03% | 3.33% |
AQB | -1.11% | $3.06M | -52.64% | 0.00% |
CL | 1.25% | $71.47B | -9.09% | 2.29% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
ARKG | 68.53% | $1.02B | 0.75% |
GNOM | 65.07% | $43.17M | 0.5% |
ARKK | 60.05% | $6.06B | 0.75% |
NUSC | 59.91% | $1.11B | 0.31% |
MOAT | 59.78% | $13.76B | 0.47% |
SMOT | 59.61% | $410.01M | 0.49% |
VBK | 59.55% | $18.40B | 0.07% |
IWO | 59.52% | $11.30B | 0.24% |
XHE | 59.45% | $172.76M | 0.35% |
SCHA | 59.29% | $16.76B | 0.04% |
KJUL | 59.18% | $117.87M | 0.79% |
KOMP | 59.15% | $2.59B | 0.2% |
IWM | 59.09% | $62.96B | 0.19% |
VTWO | 59.05% | $12.19B | 0.07% |
ISCG | 59.04% | $662.94M | 0.06% |
VB | 59.02% | $63.05B | 0.05% |
ESML | 58.89% | $1.78B | 0.17% |
IBUY | 58.75% | $146.65M | 0.65% |
SMMD | 58.55% | $1.42B | 0.15% |
KJAN | 58.51% | $284.74M | 0.79% |